125 related articles for article (PubMed ID: 37838297)
1. Erchen decoction alleviates the progression of NAFLD by inhibiting lipid accumulation and iron overload through Caveolin-1 signaling.
Deng G; Li J; Huang M; Li Y; Shi H; Wu C; Zhao J; Qin M; Liu C; Yang M; Wang Y; Zhang Y; Liao Y; Zhou C; Yang J; Xu Y; Liu B; Gao L
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117320. PubMed ID: 37838297
[TBL] [Abstract][Full Text] [Related]
2. Caveolin-1 is critical for hepatic iron storage capacity in the development of nonalcoholic fatty liver disease.
Deng GH; Wu CF; Li YJ; Shi H; Zhong WC; Hong MK; Li JJ; Zhao JM; Liu C; Qin MC; Zeng ZY; Zhang WM; Yung KKL; Lv ZP; Gao L
Mil Med Res; 2023 Nov; 10(1):53. PubMed ID: 37941054
[TBL] [Abstract][Full Text] [Related]
3. [
Deng G; Jia H; Li Y; Li J; Wu C; Shi H; Qin M; Zhao J; Liu C; Liao Y; Gao L
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Aug; 43(8):1287-1296. PubMed ID: 37712264
[TBL] [Abstract][Full Text] [Related]
4. Exocarpium Citri Grandis alleviates the aggravation of NAFLD by mitigating lipid accumulation and iron metabolism disorders.
Deng G; Liu C; Zhao J; Wang M; Li Y; Yang M; Ye H; Li J; Qin M; Wu C; Shi H; Liao Y; Zhou Z; Zhang S; Lam Yung KK; Gao L
J Ethnopharmacol; 2023 Sep; 313():116559. PubMed ID: 37116730
[TBL] [Abstract][Full Text] [Related]
5. Network pharmacology-based investigation to explore the effect and mechanism of Erchen decoction against the nonalcoholic fatty liver disease.
Liu H; Xu J; Li H; Zhang L; Xu P
Anat Rec (Hoboken); 2021 Nov; 304(11):2605-2619. PubMed ID: 34536264
[TBL] [Abstract][Full Text] [Related]
6. [Effect of Erchen Decoction on liver mitochondrial function by inhibiting mTORC1/SREBP1/CAV1 pathway in mice with high-fat diet].
Ding SS; Zhuang Y; Liao Y; Kang J; Zhang LY; Shen JY; Liao LH
Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(3):763-769. PubMed ID: 38621880
[TBL] [Abstract][Full Text] [Related]
7. Erchen Decoction alleviates obesity-related hepatic steatosis via modulating gut microbiota-drived butyric acid contents and promoting fatty acid β-oxidation.
Zhang L; Chen N; Zhan L; Bi T; Zhou W; Zhang L; Zhu L
J Ethnopharmacol; 2023 Dec; 317():116811. PubMed ID: 37336336
[TBL] [Abstract][Full Text] [Related]
8. Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity.
Cao YN; Yue SS; Wang AY; Xu L; Hu YT; Qiao X; Wu TY; Ye M; Wu YC; Qi R
J Ethnopharmacol; 2022 Jun; 292():115146. PubMed ID: 35304272
[TBL] [Abstract][Full Text] [Related]
9. Xie Zhuo Tiao Zhi formula modulates intestinal microbiota and liver purine metabolism to suppress hepatic steatosis and pyroptosis in NAFLD therapy.
Qiu J; Chen L; Zhang L; Xu F; Zhang C; Ren G; Chang K; He G; Du Z; Le Y; Yu Z; Li S; Liu Q; Dou X
Phytomedicine; 2023 Dec; 121():155111. PubMed ID: 37804819
[TBL] [Abstract][Full Text] [Related]
10. Tetrahydropalmatine ameliorates hepatic steatosis in nonalcoholic fatty liver disease by switching lipid metabolism via AMPK-SREBP-1c-Sirt1 signaling axis.
Yin X; Liu Z; Wang J
Phytomedicine; 2023 Oct; 119():155005. PubMed ID: 37562090
[TBL] [Abstract][Full Text] [Related]
11. Emodin palliates high-fat diet-induced nonalcoholic fatty liver disease in mice via activating the farnesoid X receptor pathway.
Shen C; Pan Z; Wu S; Zheng M; Zhong C; Xin X; Lan S; Zhu Z; Liu M; Wu H; Huang Q; Zhang J; Liu Z; Si Y; Tu H; Deng Z; Yu Y; Liu H; Zhong Y; Guo J; Cai J; Xian S
J Ethnopharmacol; 2021 Oct; 279():114340. PubMed ID: 34171397
[TBL] [Abstract][Full Text] [Related]
12. Caveolin-1 alleviates lipid accumulation in NAFLD associated with promoting autophagy by inhibiting the Akt/mTOR pathway.
Xue W; Wang J; Jiang W; Shi C; Wang X; Huang Y; Hu C
Eur J Pharmacol; 2020 Mar; 871():172910. PubMed ID: 31926991
[TBL] [Abstract][Full Text] [Related]
13. PREX1 depletion ameliorates high-fat diet-induced non-alcoholic fatty liver disease in mice and mitigates palmitic acid-induced hepatocellular injury via suppressing the NF-κB signaling pathway.
Li Z; Wu K; Zou Y; Gong W; Wang P; Wang H
Toxicol Appl Pharmacol; 2022 Aug; 448():116074. PubMed ID: 35605788
[TBL] [Abstract][Full Text] [Related]
14. Study on the attenuated effect of Ginkgolide B on ferroptosis in high fat diet induced nonalcoholic fatty liver disease.
Yang Y; Chen J; Gao Q; Shan X; Wang J; Lv Z
Toxicology; 2020 Dec; 445():152599. PubMed ID: 32976958
[TBL] [Abstract][Full Text] [Related]
15. Acetyl-CoA Deficiency Is Involved in the Regulation of Iron Overload on Lipid Metabolism in Apolipoprotein E Knockout Mice.
Luo G; Xiang L; Xiao L
Molecules; 2022 Aug; 27(15):. PubMed ID: 35956917
[TBL] [Abstract][Full Text] [Related]
16. Rutin ameliorated lipid metabolism dysfunction of diabetic NAFLD via AMPK/SREBP1 pathway.
Liu Y; Sun Z; Dong R; Liu P; Zhang X; Li Y; Lai X; Cheong HF; Wu Y; Wang Y; Zhou H; Gui D; Xu Y
Phytomedicine; 2024 Apr; 126():155437. PubMed ID: 38394735
[TBL] [Abstract][Full Text] [Related]
17. Shenge Formula attenuates high-fat diet-induced obesity and fatty liver via inhibiting ACOX1.
Shang Z; Gao Y; Xue Y; Zhang C; Qiu J; Qian Y; Fang M; Zhang X; Sun X; Kong X; Gao Y
Phytomedicine; 2024 Jan; 123():155183. PubMed ID: 37992491
[TBL] [Abstract][Full Text] [Related]
18. Asperuloside alleviates lipid accumulation and inflammation in HFD-induced NAFLD via AMPK signaling pathway and NLRP3 inflammasome.
Shen Q; Chen Y; Shi J; Pei C; Chen S; Huang S; Li W; Shi X; Liang J; Hou S
Eur J Pharmacol; 2023 Mar; 942():175504. PubMed ID: 36641101
[TBL] [Abstract][Full Text] [Related]
19. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
Zhang J; Du H; Shen M; Zhao Z; Ye X
J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
[TBL] [Abstract][Full Text] [Related]
20. Hepatic STAMP2 mediates recombinant FGF21-induced improvement of hepatic iron overload in nonalcoholic fatty liver disease.
Kim HY; Kwon WY; Park JB; Lee MH; Oh YJ; Suh S; Baek YH; Jeong JS; Yoo YH
FASEB J; 2020 Sep; 34(9):12354-12366. PubMed ID: 32721044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
